Testicular lymphoma is associated with a high incidence of extranodal recurrence

Cancer

Volumn 88, Issue 1, 2000, Pages 154-161

  Fonseca, Rafael ^a   Habermann, Thomas M ^a   Colgan, Joseph P ^a   O'Neill, Brian P ^a   White, William L ^a   Witzig, Thomas E ^a   Egan, Kathleen S ^a   Martenson, James A ^a   Burgart, Lawrence J ^a   Inwards, David J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adjuvant chemotherapy; Combined modality therapy; Lymphoma; Radiotherapy; Spinal injections; Testicular neoplasms

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; ORCHIECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TESTIS TUMOR; TREATMENT OUTCOME;

ADULT; AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; ORCHIECTOMY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0033985440     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000101)88:1<154::AID-CNCR21>3.0.CO;2-T     Document Type: Article

References (45)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-60.
2. Connors JM, Klimo P, Voss N, Fairey RN, Jackson S. Testicular lymphoma: improved outcome with early brief chemotherapy. J Clin Oncol 1988;6:776-81.
3. Sussman EB, Hajdu SI, Lieberman PH, Whitmore WF. Malignant lymphoma of the testis: a clinicopathologic study of 37 cases. J Urol 1977;118:1004-7.
4. Doll DC, Weiss RB. Malignant lymphoma of the testis. Am J Med 1986;81:515-24.
5. Asensio AJ, Besses C, Palacin A, Sans-Sabrafen J. Primary testicular lymphoma. A report of 3 cases [in Spanish]. Med Clin (Barc) 1994;103:339-41.
6. Ferry JA, Harris NL, Young RH, Coen J, Zietman A, Scully RE. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994;18:376-90.
7. Poulsen MG, Roberts SJ, Taylor K. Testicular lymphomathe need for a new approach. Australas Radiol 1991;35:257-60.
8. Paladugu RR, Bearman RM, Rappaport H. Malignant lymphoma with primary manifestation in the gonad: a clinicopathologic study of 38 patients. Cancer 1980;45:561-71.
9. Read G. Lymphomas of the testis - results of treatment 1960-77. Clin Radiol 1983;32:687-92.
10. Crellin AM, Hudson BV, Bennett MH, Harland S, Hudson GV. Non-Hodgkin's lymphoma of the testis. Radiother Oncol 1993;27:99-106.
11. Duncan PR, Checa F, Gowing NF, McElwain TJ, Peckham MJ. Extranodal non-Hodgkin's lymphoma presenting in the testicle: a clinical and pathologic study of 24 cases. Cancer 1980;45:1578-84.
12. Kiely JM, Massey BD Jr., Harrison EG Jr., Utz DC. Lymphoma of the testis. Cancer 1970;26:847-52.
13. Talerman A. Primary malignant lymphoma of the testis. J Urol 1977;118:783-6.
14. Jackson SM, Montessori GA. Malignant lymphoma of the testis: review of 17 cases in British Columbia with survival related to pathological subclassification. J Urol 1980;123: 881-3.
15. Turner RR, Colby TV, MacKintosh FR. Testicular lymphomas: a clinicopathologic study of 35 cases. Cancer 1981;48: 2095-102.
16. Tepperman BS, Gospodarowicz MK, Bush RS, Brown TC. Non-Hodgkin lymphoma of the testis. Radiology 1982;142: 203-8.
17. Ciatto S, Cionini L. Malignant lymphoma of the testis. Acta Radiol Oncol Radiat Phys Biol 1979;18:572-6.
18. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
19. Hayes MM, Sacks MI, King HS. Testicular lymphoma. A retrospective review of 17 cases. S Afr Med J 1983;64:1014-6.
20. Baldetorp LA, Brunkvall J, Cavallin-Stahl E, Henrikson H, Holm E, Olsson AM, et al. Malignant lymphoma of the testis. Br J Urol 1984;56:525-30.
21. Nonomura N, Okuyama A, Nakano E, Matsuda M, Ueda T, Aozasa K, et al. Malignant lymphoma of testis: a clinicopathologic study of twenty-six cases [in Japanese]. Hinyokika Kiyo 1989;35:819-27.
22. Martenson JA Jr., Buskirk SJ, Ilstrup DM, Banks PM, Evans RG, Colgan JP, et al. Patterns of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol 1988;6:297-302.
23. Ikeda Y, Nakazawa S, Kudo M. Intracranial malignant lymphoma developing 20 years after total removal of testicular malignant lymphoma - case report. Neurol Med Chir (Tokyo) 1986;26:68-70.
24. Touroutoglou N, Dimopoulos MA, Younes A, Hess M, Pugh W, Cox J, et al. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol 1995;13:1361-7.
25. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
26. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-94.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
28. Fonseca R, Inwards DJ, Habermann TM, Colgan JP, White WL, Witzig TE, et al. Testicular lymphoma, high incidence of extranodal relapse [abstract]. Blood 1995;86 (Suppl 1):533a.
29. Stull DM, Hollis LS, Gregory RE, Sheidler VR, Grossman SA. Pain in a comprehensive cancer center: more frequently due to treatment than underlying tumor [abstract]. Program/ Proc Am Soc Clin Oncol 1996;15:531.
30. Beretta F, Sanna P, Ghielmini M, Marini G, Cavalli F. Paraplegia following intrathecal chemotherapy [in German]. Schweiz Med Wochenschr 1996;126:1107-11.
31. Bellon JR, Smith AS, Cohen ML. Ascending cord necrosis. Complication of intrathecal chemotherapy with radiologicpathologic correlation. Clin Pediatr (Phila) 1995;34:506-9.
32. Garcia-Tena J, Lopez-Andreu JA, Ferris J, Menor F, Mulas F, Millet E, et al. Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1995;12:377-85.
33. Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995;38:51-7.
34. McLean DR, Clink HM, Ernst P, Coates R, al Kawi MZ, Bohlega S, et al. Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes. Cancer 1994;73:3037-40.
35. Frytak S, Shaw JN, Lee RE, Eagan RT, Shaw EG, Richardson RL, et al. Treatment toxicities in long-term survivors of limited small cell lung cancer. Cancer Invest 1988;6:669-76.
36. Fonseca R, O'Neill BP, Foote RL, Grill JP, Sloan JA, Frytak S. Cerebral toxicity in patients treated for small cell carcinoma of the lung. Mayo Clin Proc 1999;74:461-5.
37. Frytak S, Shaw JN, O'Neill BP, Lee RE, Eagan RT, Shaw EG, et al. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol 1989;12:27-33.
38. Kristjansen PE, Hansen HH. Prophylactic cranial irradiation in small cell lung cancer - an update. Lung Cancer 1995;12 (Suppl 3):S23-40.
39. Durr ED, Bonner JA, Strickler JG, Martenson JA, Chen MG, Habermann TM, et al. Management of stage IE primary gastric lymphoma. Acta Haematol 1995;94:59-68.
40. O'Neill BP, O'Fallon JR, Earle ID, Colgan JP, Brown LD, Krigel RL. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 1995;33:663-73.
41. Freilich RJ, Delattre JY, Monjour A, DeAngelis LM. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996; 46:435-9.
42. Burger PC, Scheithauer BW, Lee RR, O'Neill BP. An interdisciplinary approach to avoid the overtreatment of patients with central nervous system lesions. Cancer 1997; 80:2040-6.
43. Freilich RJ, DeAngelis LM. Primary central nervous system lymphoma. Neurol Clin 1995;13:901-14.
44. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O'Fallon JR, Kelly PJ, et al. Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg 1995;82:558-66.
45. Riemersma S, Schop R, Hooijer R, Hermans J, Kramer M, Looijenga L, et al. Large B-cell lymphomas with loss of HLA class I and II show extensive loss of heterozygosity at 6p21.3 [abstract]. Blood 1998;92 (Suppl 1):409a.